Sarissa Capital Management LP Long-Term Concentrated

CIK: 0001577524 · Show all filings

Period: Q3 2023 (← Previous) (Next →)

Filing Date: Nov 14, 2023

Total Value ($000): $742,380 (100.0% shares, 0.0% debt)

Holdings (11)

ALKS ALKERMES PLC 26.6%

Value ($000) $197,252 Shares 7,042,200 Est. Cost $24.39 Unrealized +20.2%

BIIB BIOGEN INC 22.3%

Value ($000) $165,257 Shares 643,000 Est. Cost $278.12 Unrealized -3.8%

IRWD IRONWOOD PHARMACEUTICALS INC 21.3%

Value ($000) $157,836 Shares 16,390,000 Est. Cost $11.52 Unrealized -14.9%

INVA INNOVIVA INC 12.7%

Value ($000) $94,528 Shares 7,277,000 Est. Cost $13.02 Unrealized -0.3%

GILD GILEAD SCIENCES INC 9.3%

Value ($000) $68,975 Shares 920,400 Est. Cost $55.33 Unrealized +27.7%

NBIX NEUROCRINE BIOSCIENCES INC 5.5%

Value ($000) $41,175 Shares 366,000 Est. Cost $100.50 Unrealized +4.8%

— AMARIN CORP PLC 1.3%

Value ($000) $9,607 Shares 10,442,453 Est. Cost $2.33 Unrealized —

BCRX BIOCRYST PHARMACEUTICALS INC 0.7%

Value ($000) $5,487 Shares 775,000 Est. Cost $4.84 Unrealized +48.4%

— VOR BIOPHARMA INC 0.2%

Value ($000) $1,310 Shares 618,000 Est. Cost $43.10 Unrealized —

— MERSANA THERAPEUTICS INC 0.1%

Value ($000) $699 Shares 550,000 Est. Cost $9.56 Unrealized —

— REGULUS THERAPEUTICS INC 0.0%

Value ($000) $254 Shares 185,183 Est. Cost $2.07 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ALKS	ALKERMES PLC	7,042,200	$197,252	26.6%	$24.39	+20.2%	SHS	G01767105
BIIB	BIOGEN INC	643,000	$165,257	22.3%	$278.12	-3.8%	COM	09062X103
IRWD	IRONWOOD PHARMACEUTICALS INC	16,390,000	$157,836	21.3%	$11.52	-14.9%	COM CL A	46333X108
INVA	INNOVIVA INC	7,277,000	$94,528	12.7%	$13.02	-0.3%	COM	45781M101
GILD	GILEAD SCIENCES INC	920,400	$68,975	9.3%	$55.33	+27.7%	COM	375558103
NBIX	NEUROCRINE BIOSCIENCES INC	366,000	$41,175	5.5%	$100.50	+4.8%	COM	64125C109
—	AMARIN CORP PLC	10,442,453	$9,607	1.3%	$2.33	—	SPONS ADR NEW	023111206
BCRX	BIOCRYST PHARMACEUTICALS INC	775,000	$5,487	0.7%	$4.84	+48.4%	COM	09058V103
—	VOR BIOPHARMA INC	618,000	$1,310	0.2%	$43.10	—	COM	929033108
—	MERSANA THERAPEUTICS INC	550,000	$699	0.1%	$9.56	—	COM	59045L106
—	REGULUS THERAPEUTICS INC	185,183	$254	0.0%	$2.07	—	COM	75915K309